TrialThe New England journal of medicine2021
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
Hana M El Sahly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
381 papers cite itlatest 60 shown
this paperpooled ittrialcites it